ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,936.90
-0.10%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
-0.01%
Brent Oil
82.275
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. CV Therapeutics (MM) (CVTX)

  7. CV Therapeutics (MM) (CVTX) ニュース

CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CVTX
日付受信時刻ニュースソース見出しコード企業名
2009/04/1806 : 01Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1805 : 32Edgar (US Regulatory)(25-NSE)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1805 : 15Business WireGilead Sciences Completes Acquisition of CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1802 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1706 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1706 : 00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1705 : 55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1604 : 54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1419 : 09Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1419 : 06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1406 : 23Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1406 : 09Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 53Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1005 : 03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/1004 : 11Edgar (US Regulatory)Schedule 13GNASDAQ:CVTXCV Therapeutics (MM)
2009/04/0904 : 27Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/0823 : 49MarketwiredAnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIPNASDAQ:CVTXCV Therapeutics (MM)
2009/04/0708 : 50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/0705 : 12Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CVTXCV Therapeutics (MM)
2009/04/0703 : 02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:CVTX

最近閲覧した銘柄

FX
USDEUR
US Dollar vs Euro
CCOM
US30
US 30
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
USI
USTECH100
US Tech 100
AMEX
XLF
Financial Select Sector
SPI
SP500
S&P 500
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
NYSE
CVX
Chevron
COIN
BTCUSD
Bitcoin
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有